Nurix Therapeutics, Inc. ( NRIX) - Stock Earnings
NRIX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -41.5 million USD | 16.6 million USD |
| 2024Q4 | -56.4 million USD | 18.5 million USD |
| 2025Q4 | -87.2 million USD | 6.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NRIX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -143.9 million USD | 77.0 million USD |
| 2024 | -193.6 million USD | 54.5 million USD |
| 2025 | -264.5 million USD | 84.0 million USD |
| 2026 Est. | — | — |
NRIX
Price: $26.80
52 week price:
Earnings Per Share: 2.43 USD
P/E Ratio: 10.05
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 161700
Market Capitalization: 2.7 billion